Abstract
This study reports a clinicopathological analysis of 105 patients whose liver histology showed a pattern of alcohol-like steatohepatitis. There were 32 nonalcoholic, 21 asymptomatic ambulatory, and 52 hospitalized alcoholic hepatitis patients. Female sex, obesity, and diabetes predominated in nonalcoholics. Clinical and laboratory presentation were similar in nonalcoholics and ambulatory alcoholics, but different from the hospitalized alcoholics. Histology showed an increasing degree of severity of hepatocellular damage. Mallory bodies, neutrophil and mononuclear infiltration, and pericellular and portal fibrosis from the nonalcoholics to the hospitalized alcoholics, with ambulatory alcoholics displaying an intermediate degree of severity. Steatosis and glycogenated nuclei were prevalent in the obese, diabetic nonalcoholics, of whom 47% had significant fibrosis and 8% cirrhosis, the latter present in 38% and 89% of ambulatory and hospitalized alcoholic hepatitis (P=0.0001), respectively. In asymptomatic subjects with suspected liver disease, a liver biopsy is the only way of establishing the type and severity of liver lesions.
Similar content being viewed by others
References
Beckett AG, Livingstone AV, Hill KR: Acute alcoholic hepatitis. Br Med J 1:1113–1119, 1961
Leevy CM, Tamburro CH, Zetterman R: Liver disease of the alcoholic. Med Clin North Am 59:909–918, 1975
Mendenhall CL: Alcoholic hepatitis.In Diseases of the liver, 7th ed. L Schiff, ER Schiff (eds). Philadelphia. JB Lippincott. 1993, pp 856–874
Galambos JT: Alcoholic hepatitis.In Clinical Hepatology: History, Present State, Outlook, G Csomós, H Thaler (eds). New York. Springer-Verlag, 1983, pp 321–335
Baptista A, Bianchi L, de Groote J, Desmet VJ, Gedigk P, Korb G, MacSween RNM, Popper H, Poulsen H, Scheuer PJ, Schmid M, Thaler H, Wepler W: Alcoholic liver disease: morphological manifestations. Review by an international group. Lancet 1:707–711, 1981
MacSween RNM, Burt AD: Histologic spectrum of alcoholic liver disease. Semin Liver Dis 6:221–232, 1986
Ludwig J, Viggiano TR, McGill DB, Ott BJ: Nonalcoholic steatohepatitis. Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 55:434–438, 1980
Lee RG: Nonalcoholic steatohepatitis: A study of 49 patients. Hum Pathol 20:594–598, 1989
Powell EE, Cooksley WGE, Hanson R, Searle J, Halliday JW, Powell LW: The natural history of nonalcoholic steatohepatitis: A follow-up study of forty-two patients for up to 21 years. Hepatology 11:74–80, 1990
Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA: Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 107:1103–1109, 1994
Grimm IS, Schindler W, Haluszka O: Steatohepatitis and fatal hepatic failure after biliopancreatic diversion. Am J Gastroenterology 87:775–779, 1992
Nazim M, Stamp G, Hodgson HJF: Non-alcoholic steatohepatitis associated with small intestinal diverticulosis and bacterial overgrowth. Hepato-Gastroenterology 36:349–351, 1989
Itoh S, Yougel T, Kawagoe K: Comparison between nonalcoholic steatohepatitis and alcoholic hepatitis. Am J Gastroenterol 82:650–654, 1987
Diehl AM, Goodman Z, Ishak KG: Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology 95:1056–1062, 1988
Bouchier IAD, Hislop WS, Prescott RJ. A prospective study of alcoholic liver disease and mortality. J Hepatol 16:290–297, 1992
Chedid A, Mendenhall CL, Gartside P, French SW, Chen T, Rabin L, VA Cooperative Study Group: Prognostic factors in alcoholic liver disease. Am J Gastroenterol 86:210–216, 1991
Epstein FM, Higgins M: Epidemiology of obesity.In Obesity, P Bjorntrop, BN Brodoff (eds). Philadelphia. JB Lippincott, 1992, pp. 300–342
National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039–1052, 1979
Itoh S, Igarashi M, Tsukada Y, Ichinoe A: Nonalcoholic fatty liver with alcoholic hyalin after long-term glucocorticoid therapy. Acta Hepatogastroenterol 24:415–418, 1977
Pinto HC, Baptista A, Camilo ME, Costa EB, Valente A, Moura MC: Tamoxifen associated steatohepatitis—report of three cases. J Hepatol 23:95–97, 1995
Lecour H, Ribeiro AT, Amaral I, Rodrigues MA: Prevalência do anticorpo de superficie da hepatite B na população portuguesa. O Medieo 99:645–653, 1981
Adler M, Shaffner F: Fatty liver hepatitis and cirrhosis in obese patients. Am J Med 67:811–816, 1979
Falchuk KR, Fiske SC, Haggitt RC, Federman M, Trey C: Pericentral hepatic fibrosis and intracellular hyaline in diabetes mellitus. Gastroenterology 78:835–841, 1980
Moran JR, Ghishan FK, Halter SA, Greene HL: Steatohepatitis in obese children: A cause of chronic liver dysfunction. Am J Gastroenterol 78:374–377, 1983
Rashid M, Weber JL, Roberts EA: Non-alcoholic steatohepatitis in children. Hepatology 20:324A, 1994 (abstract)
Cohen JA, Kaplan MM: The SGOT/SGPT ratio—an indicator of alcoholic liver disease. Dig Dis Sci 24:835–838, 1979
Scheuer PJ, Ashrafzadeh P, Sherlock S, Brown D, Dusheiko GM: The pathology of hepatitis C. Hepatology 15:567–571, 1995
Goodman Z, Ishak KG: Histopathology of hepatitis C virus infection. Semin Liver Dis 15:70–81, 1995
Rogers DW, Lee CH, Pound DC, Kumar S, Cummings OW, Lumeng L: Hepatitis C virus does not cause nonalcoholic steatohepatitis. Dig Dis Sci 37:1644–1647, 1992
Keeffe EB, Adesman PW, Stenzel P, Palmer RM: Steatosis and cirrhosis in an obese diabetic: Resolution of fatty liver by fasting. Dig Dis Sci 32:441–445, 1987
Eriksson S, Eriksson KF, Bondesson L: Nonalcoholic steatohepatitis in obesity: A reversible condition. Acta Med Scand 220:83–88, 1986
Van Ness MM, Diehl AM: Is liver biopsy useful in the evaluation of patients with chronically elevated enzymes? Ann Intern Med 111:473–478, 1989
Herlong HF: Approach to the patient with abnormal liver enzymes. Hosp Pract 11:32–38, 1994
Silverman JF, O'Brien KF, Long S, Leggett N, Khazanie PG, Pories WJ, Norris T, Caro JF: Liver pathology in morbidly obese patients with and without diabetes. Am J Gastroenterol 85:1349–1355, 1990
Nagore N, Scheuer PJ: The pathology of diabetic hepatitis. J Pathol 156:155–160, 1988
Abraham BH, Furth EE: Receiver operating characteristic analysis of glycogenated nuclei in liver biopsy specimen: Quantitative evaluation of their relationship with diabetes and obesity. Hum Pathol 25:1063–1068, 1994
Van Thiel DH, Stone BG: Diabetes mellitus and the liver, Semin Liver Dis 5:8–28, 1985
Braillon A, Capron JP: Foie et obésité. Gastroenterol Clin Biol 7:627–634, 1983
Braillon A, Capron JP, Hervé MA, Degott C, Quenum C: Liver in obesity. Gut 26:133–139, 1985
Wanless IR, Lentz JS: Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors. Hepatology 12:1106–1110, 1990
Causse X, Gargot D, Michenet P: Stéatoses hépatiques. Première partie: stéatoses macrovésiculaires. Gastroenterol Clin Biol 19:58–65, 1995
Batman PA, Scheuer PJ: Diabetic hepatitis preceding the onset of glucose intolerance. Histopathology 9:237–243, 1985
Rosser BG, Gores GJ: Liver cell necrosis: Cellular mechanisms and clinical implications. Gastroenterology 108:252–275, 1995
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pinto, H.C., Baptista, A., Camilo, M.E. et al. Nonalcoholic steatohepatitis. Digest Dis Sci 41, 172–179 (1996). https://doi.org/10.1007/BF02208601
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02208601